Concepedia

Harlan E. Shannon

HE

5

Publications

155

Citations

5

H-Index

1986

Active since

Affiliations

Eli Lilly (United States)(Current)

Novo Nordisk (Denmark)

Harlan E. Shannon is an author at Eli Lilly (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

1986–2001

5

Publications

5

Intrathecal pertussis toxin produces hyperalgesia and allodynia in mice

Daniel E. Womer, Neil W. DeLapp, Harlan E. Shannon · Pain · 1997 · 50 citations

, , +16

The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance

Thøger Rasmussen, Anders Fink‐Jensen, Per Sauerberg et al. · Schizophrenia Research · 2001 · 37 citations

, , +10

Butylthio[2.2.2] (NNC 11–1053/LY297802): An Orally Active Muscarinic Agonist Analgesic

Michael D.B. Swedberg, Malcolm J. Sheardown, Per Sauerberg et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 32 citations

Muscarinic agonists as analgesics. Antinociceptive activity versus M1 activity: SAR of alkylthio-TZTP's and related 1,2,5-thiadiazole analogs

Per Sauerberg, Preben H. Olesen, Malcolm J. Sheardown et al. · Life Sciences · 1995 · 21 citations

, , +10

pharmacologic and reinforcing properties of phencyclidine and the enantiomers of N-allylnormetazocine in the dog

D. Bruce Vaupel, Marcus E. Risner, Harlan E. Shannon · Drug and Alcohol Dependence · 1986 · 15 citations

, , +5

Rows per page

1–5 of 5